Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Kerinokeratosis Papulosa of Childhood.

Bauer B, Goebeler M, Weissbrich B, Kerstan A.

Dermatology. 2015;231(1):1-4. doi: 10.1159/000381539. Epub 2015 May 30.

PMID:
26044728
2.

Novel dengue virus NS2B/NS3 protease inhibitors.

Wu H, Bock S, Snitko M, Berger T, Weidner T, Holloway S, Kanitz M, Diederich WE, Steuber H, Walter C, Hofmann D, Weißbrich B, Spannaus R, Acosta EG, Bartenschlager R, Engels B, Schirmeister T, Bodem J.

Antimicrob Agents Chemother. 2015 Feb;59(2):1100-9. doi: 10.1128/AAC.03543-14. Epub 2014 Dec 8.

PMID:
25487800
3.

Adoptive immunotherapy: New assay for the identification of T cells with optimal avidity.

Weissbrich B, Nauerth M, Busch DH.

Oncoimmunology. 2013 Oct 1;2(10):e26199. Epub 2013 Sep 12.

4.

The clinical potential for koff-rate measurement in adoptive immunotherapy.

Nauerth M, Weissbrich B, Busch DH.

Expert Rev Clin Immunol. 2013 Dec;9(12):1151-3. doi: 10.1586/1744666X.2013.855609. No abstract available.

PMID:
24215403
5.

Severe conjunctivitis due to multidrug-resistant Neisseria gonorrhoeae and adenovirus 53 coinfection in a traveler returning from Thailand.

Tappe D, Mueller A, Weißbrich B, Schubert J, Schargus M, Stich A.

J Travel Med. 2013 Nov-Dec;20(6):403-6. doi: 10.1111/jtm.12071. Epub 2013 Oct 10.

PMID:
24118571
6.

Mixed functional characteristics correlating with TCR-ligand koff -rate of MHC-tetramer reactive T cells within the naive T-cell repertoire.

Hombrink P, Raz Y, Kester MG, de Boer R, Weißbrich B, von dem Borne PA, Busch DH, Schumacher TN, Falkenburg JH, Heemskerk MH.

Eur J Immunol. 2013 Nov;43(11):3038-50. doi: 10.1002/eji.201343397. Epub 2013 Aug 25.

PMID:
23893393
7.

Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation.

Schönberger K, Ludwig MS, Wildner M, Weissbrich B.

PLoS One. 2013 Jul 9;8(7):e68909. doi: 10.1371/journal.pone.0068909. Print 2013.

8.

TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer.

Nauerth M, Weißbrich B, Knall R, Franz T, Dössinger G, Bet J, Paszkiewicz PJ, Pfeifer L, Bunse M, Uckert W, Holtappels R, Gillert-Marien D, Neuenhahn M, Krackhardt A, Reddehase MJ, Riddell SR, Busch DH.

Sci Transl Med. 2013 Jul 3;5(192):192ra87. doi: 10.1126/scitranslmed.3005958.

9.

Novel respiratory syncytial virus a genotype, Germany, 2011-2012.

Prifert C, Streng A, Krempl CD, Liese J, Weissbrich B.

Emerg Infect Dis. 2013 Jun;19(6):1029-30. doi: 10.3201/eid1906.121582. No abstract available.

10.

MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy.

Dössinger G, Bunse M, Bet J, Albrecht J, Paszkiewicz PJ, Weißbrich B, Schiedewitz I, Henkel L, Schiemann M, Neuenhahn M, Uckert W, Busch DH.

PLoS One. 2013 Apr 26;8(4):e61384. doi: 10.1371/journal.pone.0061384. Print 2013.

11.

Disparate individual fates compose robust CD8+ T cell immunity.

Buchholz VR, Flossdorf M, Hensel I, Kretschmer L, Weissbrich B, Gräf P, Verschoor A, Schiemann M, Höfer T, Busch DH.

Science. 2013 May 3;340(6132):630-5. doi: 10.1126/science.1235454. Epub 2013 Mar 14.

12.

Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis.

Hansen HC, Klingbeil C, Dalmau J, Li W, Weissbrich B, Wandinger KP.

JAMA Neurol. 2013 Jan;70(1):117-9. doi: 10.1001/jamaneurol.2013.585.

13.

Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany.

Geis S, Prifert C, Weissbrich B, Lehners N, Egerer G, Eisenbach C, Buchholz U, Aichinger E, Dreger P, Neben K, Burkhardt U, Ho AD, Kräusslich HG, Heeg K, Schnitzler P.

J Clin Microbiol. 2013 Jan;51(1):155-62. doi: 10.1128/JCM.02151-12. Epub 2012 Oct 24.

14.

Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.

Brecht I, Weissbrich B, Braun J, Toyka KV, Weishaupt A, Buttmann M.

PLoS One. 2012;7(7):e40431. doi: 10.1371/journal.pone.0040431. Epub 2012 Jul 9.

15.

Clinical characteristics of pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Northern Bavaria, Germany.

Wieching A, Benser J, Kohlhauser-Vollmuth C, Weissbrich B, Streng A, Liese JG.

BMC Res Notes. 2012 Jun 18;5:304. doi: 10.1186/1756-0500-5-304.

16.

BK viremia in critically ill surgical patients with hemorrhagic or septic shock.

Nass M, Weissbrich B, Huber M, Schneider EM, Weiss M.

BMC Res Notes. 2012 Feb 16;5:100. doi: 10.1186/1756-0500-5-100.

17.

High-risk human papillomavirus infection in Bowen's disease of the nail unit: report of three cases and review of the literature.

Grundmeier N, Hamm H, Weissbrich B, Lang SC, Bröcker EB, Kerstan A.

Dermatology. 2011;223(4):293-300. doi: 10.1159/000335371. Epub 2012 Jan 24. Review.

PMID:
22269697
18.

The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.

Fehrholz M, Kendl S, Prifert C, Weissbrich B, Lemon K, Rennick L, Duprex PW, Rima BK, Koning FA, Holmes RK, Malim MH, Schneider-Schaulies J.

J Gen Virol. 2012 Mar;93(Pt 3):565-76. doi: 10.1099/vir.0.038919-0. Epub 2011 Dec 14.

PMID:
22170635
19.

Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.

Sauerbrei A, Bohn K, Heim A, Hofmann J, Weissbrich B, Schnitzler P, Hoffmann D, Zell R, Jahn G, Wutzler P, Hamprecht K.

Antivir Ther. 2011;16(8):1297-308. doi: 10.3851/IMP1870.

PMID:
22155911
20.

HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high.

Kasang C, Kalluvya S, Majinge C, Stich A, Bodem J, Kongola G, Jacobs GB, Mlewa M, Mildner M, Hensel I, Horn A, Preiser W, van Zyl G, Klinker H, Koutsilieri E, Rethwilm A, Scheller C, Weissbrich B.

PLoS One. 2011;6(8):e23091. doi: 10.1371/journal.pone.0023091. Epub 2011 Aug 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk